ART26.12, a novel fatty acid-binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models

Painful neuropathy is a pathological condition caused by numerous factors including diabetes, chemotherapy or cancer. ART26.12 is a novel fatty acid-binding protein 5 inhibitor, which our group showed could prevent and treat persistent pain in a preclinical model of oxaliplatin-induced peripheral ne...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pain 2025-02, Vol.29 (2), p.e4718
Hauptverfasser:	Warren, W G, Osborn, M, David-Pereira, A, Tsantoulas, C, Xue, Wenwen, Yates, A, OSullivan, S E
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics - pharmacology Analgesics - therapeutic use Animals Diabetic Neuropathies - drug therapy Disease Models, Animal Fatty Acid-Binding Proteins - antagonists & inhibitors Female Hyperalgesia - drug therapy Male Neuralgia - drug therapy Original Paclitaxel Pain Peripheral Nervous System Diseases - chemically induced Peripheral Nervous System Diseases - drug therapy Rats Rats, Sprague-Dawley
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!